Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Blaylock

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Health Affairs Scholar|April 15, 2026
The changing Part D landscapeGeoffrey Joyce, Beier Chen, Barbara Blaylock
Oncology (Williston Park, N.Y.)|October 17, 2002
Clinical trials referral resource. FlavopiridolDimitrios Colevas, Barbara Blaylock, Amy Gravell
Journal of Medical Economics|January 31, 2020
Real-world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with heminBarbara Blaylock, Josh Epstein, Paul Stickler
JAMA|February 14, 2025
Cost Sharing for Preferred Branded Drugs in Medicare Part DErin Trish, Barbara Blaylock, Karen Van Nuys
JAMA Network Open|August 1, 2025
Formulary Restrictions and Relapse Episodes in Persons With Relapsing-Remitting Multiple SclerosisBarbara Blaylock, Karen Van Nuys, Geoffrey Joyce
Health Affairs (Project Hope)|March 4, 2024
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011-20Geoffrey Joyce, Barbara Blaylock, Jiafan Chen, et al.
Current Medical Research and Opinion|May 10, 2018
Systematic literature review of health-related quality of life among aggressive non-Hodgkin lymphoma survivorsVincent W Lin, Barbara Blaylock, Josh Epstein, et al.
Research on Aging|February 10, 2017
Raising the Social Security Entitlement AgeJulie Zissimopoulos, Barbara Blaylock, Dana P Goldman, et al.
The Annals of Pharmacotherapy|December 29, 2021
Development of MDS-Based Predication Model for COPD Severity in Nursing Home ResidentsBarbara Blaylock, Xiaoli Niu, H Edward Davidson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Health Affairs Scholar|April 15, 2026
The changing Part D landscapeGeoffrey Joyce, Beier Chen, Barbara Blaylock
Oncology (Williston Park, N.Y.)|October 17, 2002
Clinical trials referral resource. FlavopiridolDimitrios Colevas, Barbara Blaylock, Amy Gravell
Journal of Medical Economics|January 31, 2020
Real-world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with heminBarbara Blaylock, Josh Epstein, Paul Stickler
JAMA|February 14, 2025
Cost Sharing for Preferred Branded Drugs in Medicare Part DErin Trish, Barbara Blaylock, Karen Van Nuys
JAMA Network Open|August 1, 2025
Formulary Restrictions and Relapse Episodes in Persons With Relapsing-Remitting Multiple SclerosisBarbara Blaylock, Karen Van Nuys, Geoffrey Joyce
Health Affairs (Project Hope)|March 4, 2024
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011-20Geoffrey Joyce, Barbara Blaylock, Jiafan Chen, et al.
Current Medical Research and Opinion|May 10, 2018
Systematic literature review of health-related quality of life among aggressive non-Hodgkin lymphoma survivorsVincent W Lin, Barbara Blaylock, Josh Epstein, et al.
Research on Aging|February 10, 2017
Raising the Social Security Entitlement AgeJulie Zissimopoulos, Barbara Blaylock, Dana P Goldman, et al.
The Annals of Pharmacotherapy|December 29, 2021
Development of MDS-Based Predication Model for COPD Severity in Nursing Home ResidentsBarbara Blaylock, Xiaoli Niu, H Edward Davidson, et al.
Pageof 1